Mocroft A, Youle M, Morcinek J, Sabin C A, Gazzard B, Johnson M A, Phillips A N
Department of Primary Care and Population Sciences, Royal Free Hospital School of Medicine, London.
BMJ. 1997 Feb 8;314(7078):409-13. doi: 10.1136/bmj.314.7078.409.
To estimate median survival and changes in survival in patients diagnosed as having AIDS.
Prospective observational study.
Clinics in two large London hospitals.
2625 patients with AIDS seen between 1982 and July 1995.
Survival, estimated using lifetable analyses, and factors associated with survival, identified from Cox proportional hazards models.
Median survival (20 months) was longer than previous estimates. The CD4 lymphocyte count at or before initial AIDS defining illness decreased significantly over time from 90 x 10(6)/1 during 1987 or earlier to 40 x 10(6)/1 during 1994 and 1995 (P < 0.0001). In the first three months after diagnosis, patients in whom AIDS was diagnosed after 1987 had a much lower risk of death (relative risk 0.44, 95% confidence interval 0.22 to 0.86; P = 0.017) than patients diagnosed before 1987. When the diagnosis was based on oesophageal candidiasis or Kaposi's sarcoma, patients had a lower risk of death than when the diagnosis was based on Pneumocystis carinii pneumonia (0.21 (0.07 to 0.59). P = 0.0030 and 0.37 (0.16 to 0.83), P = 0.016). Three months after AIDS diagnosis, the risk of death was similar in patients whose diagnosis was made after and before 1987 (1.02 (0.79 to 1.31), P = 0.91). There were no differences in survival between patients diagnosed during 1988-90, 1991-3, or 1994-5.
In later years, patients were much more likely to survive their initial illness, but long term survival has remained poor. The decrease in CD4 lymphocyte count at AIDS diagnosis indicates that patients are being diagnosed as having AIDS at ever more advanced stages of immunodeficiency.
评估确诊为艾滋病患者的中位生存期及生存期变化。
前瞻性观察性研究。
伦敦两家大型医院的诊所。
1982年至1995年7月间诊治的2625例艾滋病患者。
采用寿命表分析评估生存期,并通过Cox比例风险模型确定与生存期相关的因素。
中位生存期(20个月)长于先前估计。初次艾滋病定义疾病时或之前的CD4淋巴细胞计数随时间显著下降,从1987年或更早时的90×10⁶/升降至1994年和1995年的40×10⁶/升(P<0.0001)。在诊断后的前三个月,1987年后确诊艾滋病的患者死亡风险(相对风险0.44,95%置信区间0.22至0.86;P=0.017)比1987年前确诊的患者低得多。当诊断基于食管念珠菌病或卡波西肉瘤时,患者的死亡风险低于基于卡氏肺孢子虫肺炎的诊断(分别为0.21(0.07至0.59),P=0.0030和0.37(0.16至0.83),P=0.016)。艾滋病诊断三个月后,1987年后和1987年前确诊的患者死亡风险相似(1.02(0.79至1.31),P=0.91)。1988 - 90年、1991 - 3年或1994 - 5年确诊的患者生存期无差异。
近年来,患者在初次患病后存活的可能性大大增加,但长期生存率仍然很低。艾滋病诊断时CD4淋巴细胞计数的下降表明患者在免疫缺陷的更晚期阶段被诊断为艾滋病。